Breath analysis system Mistral

Mistral is an innovative diagnostic technology developed from the research collaboration between the University of Bari and Predict, an Apulian company specialized in in-vivo diagnostic systems and a partner of GE Healthcare. The technology is based on breath analysis, a science that examines the organic compounds present in exhaled breath. With a simple puff, Mistral collects these compounds in a cartridge, which is then sent to a specialized laboratory. This enables early and non-invasive diagnosis of a wide range of gastro-intestinal diseases, including colorectal cancer. - How it works: - The patient visits a hospital, pharmacy, or doctor's office to take the test. - The patient blows into a disposable mouthpiece. - The device collects the breath sample into a cartridge. - The cartridge is sent to an analysis laboratory for examination. - The diagnostic report is transmitted to the hospital and delivered to the patient. - Benefits: - For the patient: Non-invasive diagnosis and shorter waiting lists. - For the physician: A safe, compact, portable, and easy-to-use device that can be connected to a PC, tablet, or smartphone via Wi-Fi. - For the healthcare system: Reduction in prevention costs and increased target population for screening. - Application: - Early and non-invasive diagnosis of a wide range of gastro-intestinal pathologies, such as colorectal cancer, through breath analysis. Technical Specifications / Features: - Breath-based diagnostic technology - Sample collection via disposable mouthpiece - Sample stored in a cartridge - Non-invasive and early diagnosis - Portable and compact device - Wi-Fi connectivity (PC, tablet, smartphone) - Developed in partnership with the University of Bari and Predict - Specialized for gastro-intestinal disease screening